The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Refund fraud is no longer just opportunistic abuse of return policies. Instead, it has evolved into a structured underground marketplace where fraud techniques are packaged and sold like digital ...
C3.ai Inc reports fiscal third-quarter earnings after the market close Wednesday, delivering results that will test whether surging federal demand can counter intensifying competitive threats in the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Please provide your email address to receive an email when new articles are posted on . Pegcetacoplan reduced proteinuria in patients with rare complement-mediated glomerular diseases vs. placebo.
Numerous missteps have weighed on C3.ai, while Palantir Technologies has excelled. The company's new CEO will need time to steer the ship in the right direction. Consistently positive free cash flow ...
Pegcetacoplan (Empaveli) reduced proteinuria and helped stabilize kidney function in patients with C3 glomerulopathy or immune-complex membranoproliferative glomerulonephritis (MPGN). The C3 and C3b ...
Hosted on MSN
Can C3.ai Be a Good Contrarian Stock?
C3.ai stock has lost half its value this year. The company reported a brutal quarter recently, with both its top and bottom lines looking worse. It has a new CEO who has helped a couple of businesses ...
C3.ai’s (AI) stock fell 14% after preliminary Q1 2026 results and another 5% post-full earnings. The company struggles to profit from the AI boom, unlike competitors. The Wall Street adage shifts for ...
Preliminary release (Aug 8, 2025) revenue for the quarter was $70.2 to 70.4 mm. Consensus calls for revenue of $93.9M and EPS of –$0.21, though management guided below Street. Focus tonight shifts to ...
C3.ai recently released preliminary numbers for the first quarter, which came in well below its guidance. The company's CEO is stepping down due to health issues, and that has played a role in the ...
Shares of C3.ai (NYSE: AI) are falling hard on Monday, down 25.4% as of 2:33 p.m. ET. The drop comes as the S&P 500 and Nasdaq Composite were mostly flat. The artificial intelligence (AI) company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results